OrbiMed Israel BioFund GP Limited Partnership, Director, 10% Owner at Novus Therapeutics, Inc. (NVUS), bought 1,292,408 shares at $3.10 ($4.0M) on 2019-05-02, disclosed to the SEC on 2019-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.10 | 646,204 | $2.0M | 50.0% |
| 2 | $3.10 | 646,204 | $2.0M | 50.0% |
| Total | $3.10 avg | 1,292,408 | $4.0M | 100% |
| Filing → |
| PHGE | BUY | 2019-12-12 | $78K | — | Filing → |